arrow
M

Mi Na Kim

yonsei university college of medicine
H指数:24
被引数:1,869

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world outcomes of lenvatinib versus sorafenib as the second-line therapy after atezolizumab plus bevacizumab in patients with hepatocellular carcinoma: a large-scale multicenter study in Korea

仑伐替尼与索拉非尼作为阿替利珠单抗联合贝伐珠单抗后肝癌患者的二线治疗真实世界疗效:一项韩国大规模多中心研究

2026-09-110
OAAI